1. Hashimoto R., Tamura T., Watanabe Y., Sakamoto A., Yasuhara N., Ito H., Nakano M., Fuse H., Ohta A., Noda T., Matsumura Y., Nagao M., Yamamoto T., Fukuhara T.*, Takayama K.*, Evaluation of broad anti-coronavirus activity of autophagy-related compounds using human airway organoids, Molecular Pharmaceutics, 2023 Mar 22;20(4):2276-87. *Corresponding author
2. Deguchi S., Kosugi K., Hashimoto R., Sakamoto A., Yamamoto M., Rafal K., Gee P., Negoro R., Noda T., Yamamoto T., Torisawa Y., Nagao M., Takayama K.*, Elucidation of the liver pathophysiology of COVID-19 patients using liver-on-a-chips, PNAS Nexus, 2023 Mar 7;2(3):pgad029. *Corresponding author
3. Bodie NM., Hashimoto R., Connolly D., Chu J., Takayama K.*, Uhal BD.*, Design of a chimeric ACE-2/Fc-silent fusion protein with ultrahigh affinity and neutralizing capacity for SARS-CoV-2 variants, Antib Ther. 2023 Jan 20;6(1):59-74. *Corresponding author
4. Yi R., Hashimoto R., Sakamoto A., Matsumura Y., Nagao M., Takahashi K., Takayama K.*, Exocyst complex component 2 is a potential host factor for SARS-CoV-2 infection, iScience, 2022 Nov 18;25(11):105427. *Corresponding author
5. Saito A., Tamura T., Zahradnik J., Deguchi S., Tabata K., Anraku Y., Kimura I., Ito J., Yamasoba D., Nasser H., Toyoda M., Nagata K., Uriu K., Kosugi Y., Fujita S., Shofa M., Monira Begum M., Shimizu R., Oda Y., Suzuki R., Ito H., Nao N., Wang L., Tsuda M., Yoshimatsu K., Kuramochi J., Kita S., Sasaki-Tabata K., Fukuhara H., Maenaka K., Yamamoto Y., Nagamoto T., Asakura H., Nagashima M., Sadamasu K., Yoshimura K., Ueno T., Schreiber G., Takaori-Kondo A.; Genotype to Phenotype Japan (G2P-Japan) Consortium, Shirakawa K., Sawa H., Irie T., Hashiguchi T., Takayama K., Matsuno K., Tanaka S., Ikeda T., Fukuhara T., Sato K., Virological characteristics of the SARS-CoV-2 Omicron BA.2.75, Cell Host Microbe. 2022 Nov 9;30(11):1540-1555.e15.
6. Hashimoto R., Takahashi J., Shirakura K., Funatsu R., Kosugi K., Deguchi S., Yamamoto M., Tsunoda Y., Morita M., Muraoka K., Tanaka M., Kanbara T., Tanaka S., Tamiya S., Tokunoh N., Kawai A., Ikawa M., Ono C., Tachibana K., Kondoh M., Obana M., Matsuura Y., Ohsumi A., Noda T., Yamamoto T., Yoshioka Y., Torisawa YS., Date H., Fujio Y., Nagao M., Takayama K.*, Okada Y.*, SARS-CoV-2 disrupts respiratory vascular barriers by suppressing Claudin-5 expression, Sci Adv. 2022 Sep 23;8(38):eabo6783. *Corresponding author
7. 出口清香、高山和雄、オルガノイドを用いた呼吸器疾患研究の最前線、特集「多分野融合による幹細胞研究の新機軸」、日本薬理学雑誌、158巻1号、p71-76、2023.